Highest dose of Mounjaro: what is it?
The highest dose of Mounjaro is 15 mg once weekly. It is reached by gradual dose increases, if tolerated, under clinician guidance.
Key facts
- Tirzepatide + B12 is $169/month (billed $169 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.
The highest dose of Mounjaro (tirzepatide) on the FDA label is 15 mg taken once weekly. Clinicians usually increase doses stepwise over time, based on your blood sugar goals, side effects, and other medicines you take. This page summarizes labeled dosing for education only. If you are using compounded tirzepatide, your dosing plan and pen or vial instructions can differ, and your prescriber and pharmacy should guide you. Vitals Vault also offers PocketMD to help you ask dosing questions using your own health history.
- The highest dose of Mounjaro is 15 mg once weekly.
- Mounjaro doses are increased gradually, typically every 4 weeks, if tolerated.
- Not everyone needs or tolerates the highest dose of Mounjaro.
- If you miss a dose, the label gives timing rules for when to take it or skip it.
What is the highest dose of Mounjaro?
Highest dose is not required
Some people reach their treatment goals at lower doses. A clinician may keep you at a dose you tolerate well rather than pushing to the maximum, especially if side effects limit eating and drinking.
Dose is individualized
Your dose can depend on blood sugar targets, other diabetes medicines, kidney function, and side effects. If you use insulin or a sulfonylurea, your clinician may adjust other medicines to reduce low blood sugar risk.
Brand vs compounded tirzepatide
Mounjaro is a brand product. Vitals Vault offers Tirzepatide (compounded, injectable) as a compounded medication, not Mounjaro. Compounded medications are prepared by a licensed pharmacy for an individual prescription and are not FDA-approved.
How the label gets you to the maximum dose
| Topic | What the FDA label says |
|---|---|
| Starting dose | 2.5 mg once weekly for 4 weeks (for treatment initiation, not intended for glycemic control). |
| Dose escalation | Increase to 5 mg once weekly after 4 weeks. If additional glycemic control is needed, increase in 2.5 mg increments after at least 4 weeks on the current dose. |
| Maximum dose | 15 mg once weekly. |
| Missed dose | If a dose is missed, administer as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. |
| Changing the weekly day | The day of weekly administration may be changed if the time between two doses is at least 3 days (72 hours). |
Why titration is gradual
Tirzepatide commonly causes gastrointestinal side effects such as nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and abdominal pain. Gradual increases are intended to improve tolerability, and your clinician may pause or slow increases if side effects are limiting.
If you are on insulin or sulfonylurea
The label notes that using tirzepatide with an insulin secretagogue (such as a sulfonylurea) or insulin can increase the risk of hypoglycemia (low blood sugar). Clinicians may reduce the dose of the sulfonylurea or insulin when starting or increasing tirzepatide.
What to know about compounded tirzepatide
Compounded tirzepatide products can differ in concentration, device, and instructions. Do not assume the Mounjaro pen schedule applies to a compounded product. Your prescribing clinician and dispensing pharmacy should provide the specific dosing and administration instructions for your prescription.
Injection and administration questions
For Mounjaro, the FDA label and Instructions for Use describe where it can be injected and how to use the pen. Your pharmacist or prescribing clinician should show you how to use it. For compounded tirzepatide, your prescriber and pharmacy provide the instructions.
When to talk to a clinician about dose changes
Side effects limit eating or drinking
If nausea, vomiting, or diarrhea is persistent, you can become dehydrated. Dehydration can worsen kidney problems, especially if you already have kidney disease or take medicines that affect fluid balance. Your clinician may slow titration or evaluate other causes.
Symptoms of low blood sugar
Shakiness, sweating, confusion, or feeling faint can be signs of hypoglycemia, particularly if you also use insulin or a sulfonylurea. Your clinician may adjust other diabetes medicines rather than increasing tirzepatide.
Severe stomach pain
Severe abdominal pain that may radiate to the back, with or without vomiting, can be a sign of pancreatitis. Pancreatitis is a serious warning on the label for tirzepatide and needs urgent medical evaluation.
Gallbladder symptoms
Right upper abdominal pain, fever, or yellowing of the skin or eyes can suggest gallbladder disease. GLP-1 based medicines, including tirzepatide, carry warnings for acute gallbladder disease, and your clinician may reassess treatment.
Neck mass or hoarseness
Tirzepatide has a boxed warning about thyroid C-cell tumors observed in rats, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Report a neck lump, trouble swallowing, or persistent hoarseness.
Pro tips for understanding your dose plan
Think in goals, not max dose
The best dose is the one that meets goals with tolerable side effects.
Track tolerability week to week
Note nausea, vomiting, diarrhea, constipation, and appetite changes to discuss at check-ins.
Mention all diabetes medicines
Insulin and sulfonylureas matter most for low blood sugar risk during titration.
Ask about missed-dose rules
The label has specific timing rules for taking or skipping a missed dose.
Compounded is not interchangeable
Use only the dosing and administration instructions your prescriber and pharmacy provide.
Frequently Asked Questions
What is the highest dose of Mounjaro?
The highest dose of Mounjaro (tirzepatide) on the FDA label is 15 mg once weekly. Doses are increased gradually and only if the current dose is tolerated, based on the prescribing information.
Whats the highest dose of Mounjaro?
The maximum labeled dose is 15 mg once weekly. A clinician decides whether you should increase, stay at a lower dose, or pause titration based on your response and side effects.
How long does it take to get to the highest dose of Mounjaro?
The FDA label increases doses in steps after at least 4 weeks on the current dose. How quickly you reach the maximum depends on whether you tolerate each step and whether additional glycemic control is needed.
What happens if I miss a dose while titrating up?
The label says to take a missed dose as soon as possible within 4 days (96 hours). If more than 4 days have passed, skip the missed dose and take the next dose on your regular day.
Is compounded tirzepatide the same as Mounjaro at the highest dose?
No. Mounjaro is a brand product, while compounded tirzepatide is prepared by a pharmacy for an individual prescription and is not FDA-approved. Your prescriber and dispensing pharmacy should provide the exact dosing and administration instructions for your compounded medication.